The study found that recipients of two doses of the Pfizer-BioNTech vaccine proved highly effective in preventing COVID-19 hospitalization among those 12-to-18-years-old. A new Centers for Disease Control and Prevention report has concluded that the two doses of the Pfizer-BioNTech vaccine have proven highly effective in preventing COVID-19 hospitalization among individuals 12 to 18.